ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading

NCT01228227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Assess the Periprocedural Myocardial Necrosis

Interventions

DRUG: ATORVASTATIN 80 mg
DRUG: ROSUVASTATIN 40 mg

Sponsor

Gennaro Sardella